Safety and Tolerability Study in Adults With Cold Agglutinin Disease Previously Treated With SAR445088 or Never Treated With SAR445088

Clinical trial NCT04802057 · TERMINATED

Trial details

NCT number: NCT04802057
Sponsor: Bioverativ, a Sanofi company
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Autoimmune Haemolytic Anaemia

Start date: 2021-03-22
Primary completion: 2025-03-04
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.